New Research Poster Presentation 2.35
A Phase III Clinical Endpoint Evaluation of HLD200 in Children With ADHD: Safety Results
A Phase III Clinical Endpoint Evaluation of HLD200 in Children With ADHD: Safety Results
Thursday, October 29, 2015 10:00 AM